Week in Review
FDA authorizes Pfizer vaccine for ages 12-15, President Biden announces cybersecurity enhancements, and more…
Week in Review
The CDC and FDA recommend pause for Johnson & Johnson vaccine, the Supreme Court halts California ban of home-based religious gatherings, and more…